Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial. (linkinghub.elsevier.com)

Authors: Schilling WHK … White NJ Journal: Lancet Infectious Diseases Published: 2026-02-01 DOI: https://doi.org/10.1016/S1473-3099(25)00482-7